Biopharma Bets Big on Antibody-Drug Conjugates
After a brief slump, interest in ADCs is at an all-time high, highlighted by a handful of recent multi-million- and billion-dollar acquisitions.
After a brief slump, interest in ADCs is at an all-time high, highlighted by a handful of recent multi-million- and billion-dollar acquisitions.
The FDA’s agenda includes an advisory committee meeting for Sarepta’s delandistrogene moxeparvovec, which, if approved, would become the first gene therapy for Duchenne muscular dystrophy.
FDA Action Alert: Sarepta, Protalix, Otsuka/Lundbeck and More Read More »
The FDA’s new guidance on decentralized clinical trials clarifies how investigators and trial sponsors can use digital health technologies and involve primary healthcare practitioners.
FDA Guidance May Bolster Confidence in Decentralized Clinical Trials Read More »
Despite multiple therapeutics approved to treat localized symptoms, there are currently no systemic therapies on the market for Sjogren’s syndrome.
Opinion: Hope on the Horizon for Sjogren’s Syndrome Read More »
La lipotoxicidad, el aumento del estrés oxidativo y la disfunción mitocondrial son varios de los mecanismos implicados.
Fisiopatología y nuevas terapias | Miocardiopatía diabética Read More »
La sostenibilidad es uno de los grandes retos de la sociedad actual y para su consecución se han puesto sobre la mesa todas las herramientas y esfuerzos disponibles. Esta urgencia llega en una etapa en la que las nuevas tecnologías han impregnado una buena parte de las relaci …
Cómo la digitalización puede ayudar a potenciar el desarrollo sostenible Read More »
The disclosure comes as cardiac monitoring device maker iRhythm also said it received a request from the Justice Department..
Boston Scientific gets DOJ subpoena for documents related to heart monitoring Read More »
Rachel Walensky, who has served as director since 2001, was criticized for the federal government’s handing of the pandemic, announcing in August last year that she planned to reorganize the CDC.
The restructuring, along with reductions in discretionary spending, are expected to save the company $17 million to $20 million by 2024.
ZimVie will lay off 5% of staff in bid to reduce costs, streamline business Read More »
Rachel Walensky, who has served as director since 2001, was criticized for the federal government’s handing of the pandemic, announcing in August last year that she planned to reorganize the CDC.